| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/03/2013 | CN102210665B Method for preparing feed antibacterial agent by absorbing and grafting potassium diformate on epidesmine molecular screen |
| 04/03/2013 | CN102188575B Oral liquid preparation for treating infantile indigestion with food retention and cough and preparation method thereof |
| 04/03/2013 | CN102188396B Lyophilized potassium sodium dehydroandroan drographolide succinate multi-vesicular liposome (MVL) powder and preparation method thereof |
| 04/03/2013 | CN102178912B Chinese medicine preparation for relieving gastral cavity crymodynia symptoms of people with yang deficiency as well as preparation method and application thereof |
| 04/03/2013 | CN102145143B Pharmaceutical composition for treatment of gastritis and preparation method of pharmaceutical composition |
| 04/03/2013 | CN102133281B Edible fungi health care pill |
| 04/03/2013 | CN102108090B Dihydroiso-coumarin glucoside compounds and preparation method and application thereof |
| 04/03/2013 | CN102086195B Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
| 04/03/2013 | CN102060904B Celosia argentea L. saponin compounds and application thereof |
| 04/03/2013 | CN102018751B Anti-hepatitis natural medicine compound preparation, preparation method and application thereof |
| 04/03/2013 | CN101974529B TGF-beta specific siRNA containing free triphosphoric acid group and application thereof |
| 04/03/2013 | CN101921225B Pirfenidone compound, preparation method and application thereof |
| 04/03/2013 | CN101904390B Liver-nourishing tea and preparation method thereof |
| 04/03/2013 | CN101857594B Tetrahydropyridoindole compounds, and preparation method and application thereof |
| 04/03/2013 | CN101801414B Oral and skin compositions |
| 04/03/2013 | CN101711814B Medicine for treating peptic ulcer, preparation method and application thereof |
| 04/03/2013 | CN101687007B Composition for prevention and/or treatment of peptic ulcer |
| 04/03/2013 | CN101605551B Use of a clay to prepare a medicament for treating or preventing coeliac disease |
| 04/03/2013 | CN101530603B Medicine for treating disease of digestive tract |
| 04/03/2013 | CN101502323B Elemental diet suitable for severe patient and patient with metabolic intestinal dysfunction as well as preparation method thereof |
| 04/03/2013 | CN101496815B Medicament for treating hepatic failure and preparation method thereof |
| 04/03/2013 | CN101444303B Dendrobium kudzu eucommia bark functional food |
| 04/03/2013 | CN101284799B Nitrogen-contained derivates of caffeoylquinic acid, method for preparing same, pharmaceutical compositions thereof and uses |
| 04/03/2013 | CN101228172B 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| 04/02/2013 | US8410266 2,4-pyrimidinediamine compounds and their uses |
| 04/02/2013 | US8410174 Method for treating arthritis |
| 04/02/2013 | US8410135 4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
| 04/02/2013 | US8410110 9-(piperazinylalkyl) carbazoles as Bax-modulators |
| 04/02/2013 | US8410105 Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors |
| 04/02/2013 | US8410057 Method of inducing T cell apoptosis by administering Altered Peptide Ligand |
| 04/02/2013 | US8410053 Methods for treating autoimmune disorders, and reagents related thereto |
| 04/02/2013 | US8409612 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 04/02/2013 | CA2585642C Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof |
| 04/02/2013 | CA2550843C Novel phenylalanine derivatives |
| 04/02/2013 | CA2532799C Human antibody molecules for il-13 |
| 04/02/2013 | CA2417963C Screening of a novel hepatic syndrome and its uses |
| 03/28/2013 | WO2013044064A1 Acetaminophen conjugates, compositions and methods of use thereof |
| 03/28/2013 | WO2013044044A2 Methods of treating fatty liver disease with helminth-derived glycan-containing compounds |
| 03/28/2013 | WO2013043960A1 Compounds useful as inhibitors of choline kinase |
| 03/28/2013 | WO2013043720A1 Regulation of sodium channels by plunc proteins |
| 03/28/2013 | WO2013043125A1 Enterovirus 71 specific antibodies and uses thereof |
| 03/28/2013 | WO2013042782A1 Condensed heterocyclic compound |
| 03/28/2013 | WO2013042378A1 Deodorant composition |
| 03/28/2013 | WO2013042156A2 Peptides having protective effect towards the inflammatory activity of peptide 31-43 of a-gliadin in celiac disease |
| 03/28/2013 | WO2013041719A1 Tripeptide kdpt for antiapoptotic treatment |
| 03/28/2013 | WO2013040952A1 Composition and method for prevention or treatment of dentin-related symptoms or diseases |
| 03/28/2013 | WO2013040873A1 Sustained and controlled release of micro-granule formulation for treating intestinal disease and preparation method thereof |
| 03/28/2013 | WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells" |
| 03/28/2013 | US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079332 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 03/28/2013 | US20130079317 Methods for treatment of diseases |
| 03/28/2013 | US20130079294 Extracts and isolated flavonoids from euphorbia cuneata useful as anti-ulcer agents |
| 03/28/2013 | US20130078237 Cd27l antigen binding proteins |
| 03/28/2013 | CA2858033A1 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | CA2849442A1 Compounds useful as inhibitors of choline kinase |
| 03/28/2013 | CA2849267A1 Regulation of sodium channels by plunc proteins |
| 03/28/2013 | CA2845183A1 Tripeptide kdpt for antiapoptotic treatment |
| 03/27/2013 | EP2573082A1 Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 03/27/2013 | EP2573081A1 Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis |
| 03/27/2013 | EP2572717A1 Pharmaceutical composition containing solifenacin |
| 03/27/2013 | EP2572713A1 Extracts and isolated flavonoids from Euphorbia cuneata useful as anti-ulcer agents |
| 03/27/2013 | EP2571879A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 03/27/2013 | EP2571532A2 Il-1 binding proteins |
| 03/27/2013 | EP2214480B1 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
| 03/27/2013 | CN1671391B Novel methods and compositions for alleviating pain |
| 03/27/2013 | CN103003299A Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease |
| 03/27/2013 | CN103003234A N-hydroxyformamide derivative and pharmaceutical containing same |
| 03/27/2013 | CN103002923A Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | CN102994457A Artificially-synthesized G4 phage and applications thereof |
| 03/27/2013 | CN102994422A Application of lactobacillus plantarum P-8 in improvement of alcoholic liver injury |
| 03/27/2013 | CN102994416A Dog source bacillus licheniformis Y10 and application thereof |
| 03/27/2013 | CN102994349A Production process of health-care tonic wine |
| 03/27/2013 | CN102994348A Black plum wine |
| 03/27/2013 | CN102994346A Base stock for preparing MACA wine |
| 03/27/2013 | CN102994345A Pollen Shou liquor (traditional Chinese medicinal liquor) |
| 03/27/2013 | CN102994344A Ginseng-based health care wine and preparation method thereof |
| 03/27/2013 | CN102994339A Medicinal liquor formula |
| 03/27/2013 | CN102994335A Medicinal liquor for nourishing and warming stomach |
| 03/27/2013 | CN102994334A Life-nourishing balsam pear yellow wine |
| 03/27/2013 | CN102994333A Female life nourishing yellow wine |
| 03/27/2013 | CN102994330A Immunity-enhancing shiitake wine |
| 03/27/2013 | CN102994329A Mulberry wine |
| 03/27/2013 | CN102994324A Fresh bamboo juice liquor and its production method |
| 03/27/2013 | CN102994322A Fructus Viticis healthcare wine for dizzy control |
| 03/27/2013 | CN102994309A Ginkgo-sorghum liquor and ginkgo-sorghum health-care liquor |
| 03/27/2013 | CN102994221A Method for extracting coix seed oil from coix seed |
| 03/27/2013 | CN102993277A Novel immunomodulatory protein, preparation method and application |
| 03/27/2013 | CN102993161A Bicyclol-leucinamide, and preparation method and application thereof |
| 03/27/2013 | CN102993153A Isoflavone-N-methyl hydroxamic acid urease inhibitor and synthesis method and use thereof |
| 03/27/2013 | CN102993152A Urease inhibitor genistein hydroxamic acid compound and synthesis and application thereof |
| 03/27/2013 | CN102993150A Flavone-N- methyl hydroxamic acid urease inhibitor, and synthesis and use thereof |
| 03/27/2013 | CN102993148A Quercetin derivatives or analogs thereof, and application thereof |
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN102993052A Aryl propionyl hydroxamic acid urease inhibitor, and synthesis and use thereof |
| 03/27/2013 | CN102989007A Method for massively preparing midkine antisense oligodeoxynucleotide nano-liposomes for injection |
| 03/27/2013 | CN102988976A Hepatitis B virus core antigen-DNA (deoxyribonucleic acid) compound vaccine and preparation method thereof |
| 03/27/2013 | CN102988959A Modulation of NKG2D |
| 03/27/2013 | CN102988951A Medicine for treating children with congestive splenomegaly |